Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNQ4 | P56696 | 3/20 | 0.36 |
| ▸ | KCNQ5 | Q9NR82 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.35 |
| ▸ | VNN1 | O95497 | 2/20 | 0.35 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.34 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.34 |
| ▸ | GSK3B | P49841 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7141522 | 0.94 | ALDH1A1 (0.42) | KCNQ4KCNQ5KDM4EALDH1A1EGLN2 | |
| SCHEMBL7145960 | 0.92 | EGLN2 (0.36) | KCNQ4KCNQ5KDM4EALDH1A1EGLN2 | |
| SCHEMBL7145884 | 0.90 | KCNQ4 (0.39) | KCNQ4KCNQ5KDM4EALDH1A1EGLN2 | |
| SCHEMBL5869054 | 0.87 | KCNQ4 (0.40) | KCNQ4KCNQ5KDM4EALDH1A1EGLN2 | |
| SCHEMBL7139979 | 0.85 | ALDH1A1 (0.40) | KDM4EALDH1A1EGLN2SIRT2SIRT1 | |
| SCHEMBL7704530 | 0.83 | DHODH (0.37) | ALDH1A1VNN1GSK3BMEN1KMT2A | |
| SCHEMBL7142038 | 0.83 | HTT (0.36) | KDM4EALDH1A1EGLN2SIRT2SIRT1 | |
| SCHEMBL7704377 | 0.82 | ALDH1A1 (0.45) | KDM4EALDH1A1VNN1GSK3BMEN1 | |
| SCHEMBL5868790 | 0.82 | KCNQ4 (0.40) | KCNQ4KCNQ5KDM4EALDH1A1EGLN2 | |
| SCHEMBL5869010 | 0.81 | KCNQ4 (0.45) | KCNQ4KCNQ5KDM4EALDH1A1EGLN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1224174-B1 | BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | HOFFMANN LA ROCHE (CH) | 2003-09-17 | — | — | EP | disclosed |
| EP-1224174-A2 | BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2002-07-24 | — | — | EP | disclosed |
| US-6407094-B1 | 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA | HOFFMANN-LA ROCHE INC. | 2002-06-18 | — | — | US | disclosed |
| WO-2001029011-A2 | BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2001-04-26 | — | — | WO | disclosed |